Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mechanisms of Resistance

Candida albicans and Staphylococcus aureus Form Polymicrobial Biofilms: Effects on Antimicrobial Resistance

Melphine M. Harriott, Mairi C. Noverr
Melphine M. Harriott
Department of Immunology and Microbiology, Wayne State University School of Medicine, Detroit, Michigan 48201
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mairi C. Noverr
Department of Immunology and Microbiology, Wayne State University School of Medicine, Detroit, Michigan 48201
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mnoverr@med.wayne.edu
DOI: 10.1128/AAC.00657-09
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • FIG. 1.
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    S. aureus biofilm growth in serum and BHI. S. aureus strain ATCC 29523 was grown overnight at 37°C in BHI broth. Cells were washed, counted and diluted into different media: bovine serum (BS), heat-inactivated bovine serum (BS HI), or BHI. (A) For biofilm formation, cultures were diluted to 107 CFU/ml, and 300-μl aliquots were added to tissue culture-treated chamber slides and incubated at 37°C for 24 h without shaking. Biofilm formation was monitored by fluorescence microscopy and SEM. (Panels 1 to 3) For fluorescence microscopy, biofilms were stained with SYTO 9 (viable microbial cells stain green) and ConA-Texas Red (extracellular matrix stains red). SA, S. aureus; Mono, monomicrobial biofilm. (Panels 4 to 6) For SEM, biofilms formed on chamber slides were processed for SEM, cut, and mounted into stubs. Magnifications, ×600 (panels 1 to 3) and ×5,000 (panels 4 to 6). Bars, 10 μm. (B) For biofilm formation, cultures were diluted to 106 CFU/ml, and 100-μl aliquots were added to tissue culture-treated 96-well plates and incubated at 37°C for 24 h without shaking. Biofilm formation was monitored by the CFU assay. Washed plates were washed after 1 h to remove nonadherent cells, while unwashed plates were left alone. Biofilms were disrupted by sonication, and the number of CFU was determined by plating. Experiments were performed in duplicate, and the results are averages of two separate trials.

  • FIG. 2.
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    Polymicrobial C. albicans-S. aureus biofilm formation in serum. C. albicans SC5314 was grown overnight in SDB at 30°C. S. aureus ATCC 29523 was grown overnight at 37°C in BHI. Both species were washed, counted, and diluted in different media. C. albicans (106 CFU/ml) and S. aureus (107 CFU/ml) were concurrently added to 96-well tissue culture-treated chamber slides and incubated for 24 h at 37°C. Biofilm formation was monitored by fluorescence microscopy and SEM (A) and CFU analysis (B). (A, panels 1 to 3) For fluorescence microscopy, biofilms were stained with calcofluor white (blue stain and blue arrows show fungal cell wall), SYTO 9 (green stain and green arrows show viable microbial cells), and ConA-Texas Red (red stain and red arrows show extracellular matrix). CA, C. albicans; Mono, monomicrobial biofilm; CA/SA Poly, C. albicans and S. aureus polymicrobial biofilm. (Panels 4 to 6) For SEM, biofilms formed on chamber slides were processed for SEM, cut, and mounted into stubs. Magnifications, ×200 (panels 1 and 2), ×1,000 (panel 3), and ×2,000 (panels 4 to 6). Bars, 20 μm. (B) For the CFU assay, plates were washed to remove nonadherent cells. Biofilms were disrupted by sonication, and the number of CFU was determined by plating onto selective media. Experiments were performed in sextuplicate. The data represent the averages of four experiments. Values that were significantly different (P < 0.01) for the S. aureus monomicrobial biofilm versus the S. aureus polymicrobial biofilm are indicated by the bars and asterisks.

  • FIG. 3.
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    Effect of polymicrobial biofilm formation on antimicrobial drug resistance. Polymicrobial biofilms were formed as described in the legend to Fig. 4 using C. albicans SC5314 (106 CFU/ml) and S. aureus ATCC 29523 (107 CFU/ml) added concurrently to 96-well tissue culture-treated plates in 50% BS. Various concentrations (in micrograms per milliliter) of vancomycin alone (A), amphotericin B alone (B), or a combination of both drugs (C) were tested. After incubation for 24 h at 37°C, the number of CFU was determined by plating onto selective media. Experiments were performed in duplicate, and the data represent the averages of two independent experiments. CA, C. albicans; SA, S. aureus; Mono, monomicrobial biofilm; Poly, polymicrobial biofilm.

  • FIG. 4.
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    Effect of separation of S. aureus and C. albicans on biofilm formation and vancomycin resistance using a Transwell system. C. albicans (106 CFU/ml) and S. aureus (107 CFU/ml) were added to either 24-well tissue culture-treated plates or 0.4-μm Transwell plates and incubated for 24 h at 37°C. For Transwell plates, S. aureus was added to the bottom of the well, and C. albicans was added to the top of the membrane to allow passage of secreted factors. Vancomycin (800 μg/ml) was added to the bottom well, and plates were incubated an additional 24 h at 37°C. The plates were washed to remove nonadherent cells, and growth was monitored by the CFU assay. Experiments were performed in duplicate, and the data represent the averages of two independent experiments. Values that were significantly different (P < 0.01) for S. aureus in a polymicrobial biofilm with no drug versus S. aureus in a polymicrobial biofilm with 800 μg/ml vancomycin are indicated by the bar and asterisks. SA, S. aureus; Mono, monomicrobial biofilm; Poly, polymicrobial biofilm.

  • FIG. 5.
    • Open in new tab
    • Download powerpoint
    FIG. 5.

    Effect of planktonic polymicrobial growth on antimicrobial drug resistance. C. albicans SC5314 (103 CFU/ml) alone, S. aureus ATCC 25923 (103 CFU/ml) alone, or C. albicans (103 CFU/ml) and S. aureus (103 CFU/ml) together were added to 96-well, deep-well polypropylene plates in 50% BS. Amp B alone, vancomycin alone, or Amp B and vancomycin combined were added to the wells. The plates were incubated at 35°C in an orbital shaker at 175 rpm for 18 h, and fungal and bacterial viability was monitored by the CFU assay. Experiments were performed in duplicate, and data represent averages of two independent experiments. CA, C. albicans; SA, S. aureus; Mono, monomicrobial biofilm; Poly, polymicrobial biofilm.

  • FIG. 6.
    • Open in new tab
    • Download powerpoint
    FIG. 6.

    Effect of C. albicans biofilm matrix on S. aureus vancomycin resistance. C. albicans biofilm matrix was isolated as described in Materials and Methods. (A) S. aureus (107 CFU/ml) was added to chamber slides in 50% BS (panel 1), BHI (panel 2), or C. albicans biofilm matrix (panel 3). After 24 h, cells were stained with SYTO 9 (viable microbial cells stain green) and ConA-Texas Red (extracellular matrix stain red). (B) S. aureus (107 CFU/ml) was added alone, with C. albicans biofilm matrix, or with C. albicans (106 CFU/ml) to 96-well tissue culture-treated plates in 50% BS. After incubation for 24 h at 37°C, the plates were washed, and vancomycin was added. The plates were incubated for an additional 24 h. The plates were washed to remove nonadherent cells, and growth was monitored by the CFU assay. Experiments were performed in duplicate, and results are representative of two independent experiments. Values that were significantly different (P < 0.01) for S. aureus monomicrobial biofilm in the presence of serum versus S. aureus in the presence of C. albicans matrix are indicated (**). CA, C. albicans; SA, S. aureus; Mono, monomicrobial biofilm; Poly, polymicrobial biofilm.

PreviousNext
Back to top
Download PDF
Citation Tools
Candida albicans and Staphylococcus aureus Form Polymicrobial Biofilms: Effects on Antimicrobial Resistance
Melphine M. Harriott, Mairi C. Noverr
Antimicrobial Agents and Chemotherapy Aug 2009, 53 (9) 3914-3922; DOI: 10.1128/AAC.00657-09

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Candida albicans and Staphylococcus aureus Form Polymicrobial Biofilms: Effects on Antimicrobial Resistance
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Candida albicans and Staphylococcus aureus Form Polymicrobial Biofilms: Effects on Antimicrobial Resistance
Melphine M. Harriott, Mairi C. Noverr
Antimicrobial Agents and Chemotherapy Aug 2009, 53 (9) 3914-3922; DOI: 10.1128/AAC.00657-09
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

amphotericin B
biofilms
Candida albicans
Staphylococcus aureus

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596